These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24464263)

  • 1. Crosstalk between insulin and Toll-like receptor signaling pathways in the central nervous system.
    Hemmati F; Ghasemi R; Mohamed Ibrahim N; Dargahi L; Mohamed Z; Raymond AA; Ahmadiani A
    Mol Neurobiol; 2014 Dec; 50(3):797-810. PubMed ID: 24464263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.
    Hu X; Chen J; Wang L; Ivashkiv LB
    J Leukoc Biol; 2007 Aug; 82(2):237-43. PubMed ID: 17502339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR Signaling in Brain Immunity.
    Guo M; Xu Y; Zhang CJ
    Handb Exp Pharmacol; 2022; 276():213-237. PubMed ID: 34761292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
    Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
    Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors and integrins crosstalk.
    Alhamdan F; Bayarsaikhan G; Yuki K
    Front Immunol; 2024; 15():1403764. PubMed ID: 38915411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases.
    Acioglu C; Heary RF; Elkabes S
    Brain Behav Immun; 2022 May; 102():163-178. PubMed ID: 35176442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.
    Hajishengallis G; Lambris JD
    Immunol Rev; 2016 Nov; 274(1):233-244. PubMed ID: 27782328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between toll-like receptors and hypoxia-dependent pathways in health and disease.
    Crifo B; Taylor CT
    J Investig Med; 2016 Feb; 64(2):369-75. PubMed ID: 26247129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor (TLR) and inflammasome actions in the central nervous system.
    Hanamsagar R; Hanke ML; Kielian T
    Trends Immunol; 2012 Jul; 33(7):333-42. PubMed ID: 22521509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
    Chinenov Y; Rogatsky I
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction.
    O'Neill LA
    Immunity; 2008 Jul; 29(1):12-20. PubMed ID: 18631453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application.
    Trudler D; Farfara D; Frenkel D
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20706642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a.
    Holst B; Raby AC; Hall JE; Labéta MO
    Anaesthesia; 2012 Jan; 67(1):60-64. PubMed ID: 22150483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors and their role in neuropathic pain and migraine.
    Liu X; Yang W; Zhu C; Sun S; Wu S; Wang L; Wang Y; Ge Z
    Mol Brain; 2022 Aug; 15(1):73. PubMed ID: 35987639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors in defense and damage of the central nervous system.
    Aravalli RN; Peterson PK; Lokensgard JR
    J Neuroimmune Pharmacol; 2007 Dec; 2(4):297-312. PubMed ID: 18040848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
    Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors in neurodegeneration.
    Okun E; Griffioen KJ; Lathia JD; Tang SC; Mattson MP; Arumugam TV
    Brain Res Rev; 2009 Mar; 59(2):278-92. PubMed ID: 18822314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between complement and toll-like receptors.
    Song WC
    Toxicol Pathol; 2012; 40(2):174-82. PubMed ID: 22109714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.